These PTPs are frequently mutated or inactivated in lung cancer, colorectal cancer, glioblastoma, head and neck squamous cell carcinomas, and renal cell carcinoma21,23,24,44–46, suggesting that their inactivation contributes to the malignancy of human cancers. This evidence concerns the gene PTS and lung carcinoma.